HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA’s Warning To Lash-Growth Firm Shows Risks In Third-Party Claims

This article was originally published in The Rose Sheet

Executive Summary

An April 18 FDA warning letter to Lifetech Resources LLC demonstrates that cosmetics firms will be held accountable when their websites feature third-party claims and testimonials that cross into drug marketing territory.

Related Content

Rodan + Fields Concealed Prostaglandin Risks From Lash Boost Users – Class Action
In Brief: Revlon Sale?; P&G/Coty Fragrance Transfer; More
Allergan Continues Legal Sparring With Cosmetic Eyelash-Growth Brands
In Brief
In Brief
MyChelle To Answer Natural Product Efficacy Questions With Imaging System
Markwins' Wet N Wild To Offer Value-Priced Lash-Growth Products In 2011
Held Off By Latisse, Lash Allure Touts Results In A Blink At Low Price Point
FDA Cites Latisse Web Site For Implying Eyelash Growth Drug Is A Cosmetic
Jan Marini Explores Anti-Aging Hair-Care Frontier With Revamped Conditioner



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts